CMS Innovation Center Announces Model Portfolio Changes to Better Protect Taxpayers and Help Americans Live Healthier Lives

Today, the CMS Innovation Center announced changes to its model portfolio to align with its statutory mandate and strategic goals.

The Center regularly assesses and may amend model activities in response to a model’s projected savings, quality outcomes data, legal compliance, operational feasibility and gaps in expected versus actual impact.

What's changing

Models Identified to End Early (Original Performance Period)

• Maryland Total Cost of Care (2019 - 2026)
• Primary Care First (2021 - 2026)
• ESRD Treatment Choices (2021 - 2027; will propose termination through rulemaking)
• Making Care Primary (2024 - 2034)

Additionally, the CMS Innovation Center is considering options to reduce the size of Integrated Care for Kids (2020 – 2026).

Further, the CMS Innovation Center will no longer pursue two previously announced but not yet implemented models given the flexibility provided by President Trump’s recission of Executive Order 14087 on January 20, 2025.

• Medicare $2 Drug List
• Accelerating Clinical Evidence

Next Steps

Participants should expect follow-up communication from their models with timelines, technical assistance and other information regarding the wind-down and close-out.

The Innovation Center will publish final evaluation reports from models ending to inform participants and other stakeholders of the important findings and insights about the tested approaches to value-based care.

The Center will share more of its new strategic vision to empower Americans to live healthier lives while protecting taxpayers in the near future.

Read more:

• Statement on CMS Innovation Center Aligning Portfolio with Statutory Obligation
• Fact sheet - CMS Innovation Center Announces Model Portfolio Changes to Better Protect Taxpayers and Help Americans Live Healthier Lives